Spinnaker Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Spinnaker Investment Group's PFE Position: Q2 2026 in Review
Spinnaker Investment Group increased its Pfizer (PFE) stake by 115% in Q2 2026, buying an estimated $319K and bringing the position to 22,810 shares worth $549K. The position accounts for 0.09% of the portfolio, ranked #92.
Spinnaker Investment Group first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Spinnaker Investment Group held 22,810 shares of Pfizer worth $549K as of Q2 2026.
- Spinnaker Investment Group bought 12,211 Pfizer shares in Q2 2026, an estimated $319K.
- Pfizer made up 0.09% of Spinnaker Investment Group's portfolio in Q2 2026, its #92 holding.
- Spinnaker Investment Group first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Spinnaker Investment Group's 13F filing for Q2 2026, filed 10 Jul 2026.